

Instance: composition-en-70fa014e07592e69938a0c03f0ec3015
InstanceOf: CompositionUvEpi
Title: "Composition for vidprevtyn Package Leaflet"
Description:  "Composition for vidprevtyn Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - vidprevtyn"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet 
1. What VidPrevtyn Beta is and what it is used for  
2. What you need to know before you receive  VidPrevtyn Beta 
3. How VidPrevtyn Beta is given 
4. Possible side effects  
5. How to store VidPrevtyn Beta 
6. Contents of the pack and other information 
         </div>"""   
          

* section[=].section[+]
  * title =  "1. What vidprevtyn is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What vidprevtyn is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>VidPrevtyn Beta is a vaccine used for preventing COVID-19. VidPrevtyn Beta is given to adults who previously received either mRNA or adenoviral vector 
COVID-19 vaccine. </p>
<p>The vaccine stimulates the immune system (the body s natural defences) to produce specific 
antibodies that work against the virus, giving protection against COVID-19. None of the ingredients 
in this vaccine can cause COVID-1</p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take vidprevtyn"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take vidprevtyn"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take vidprevtyn"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take vidprevtyn"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use VidPrevtyn Beta:<br />
If you are allergic to the active substance or any of the other ingredients of this medicine (listed in 
section 6);<br />
If you are allergic to octylphenol ethoxylate, a substance that is used in the manufacturing process. 
Small amounts of this substance may remain after manufacturing.  </p>
<p>Warnings and precautions<br />
Talk to your doctor, pharmacist or nurse before you are given the vaccine if:<br />
<em> you have ever had a severe allergic reaction after any other vaccine injection or after you were 
given VidPrevtyn Beta in the past;<br />
</em> you have ever fainted following any needle injection; 
* you have a severe illness or infection with a high temperature (over 38  C). However, you can 
have your vaccination if you have a mild fever or upper airway infection like a cold.<br />
* you have a bleeding problem, you bruise easily or you use a medicine to prevent blood clots. 
* you have a weakened immune system (immunodeficiency) or you are using medicines that 
weaken the immune system (such as high-dose corticosteroids or cancer medicines).  </p>
<p>As with any vaccine, VidPrevtyn Beta may not fully protect all those who receive it. It is not known 
how long you will be protected. </p>
<p>Children and adolescents 
VidPrevtyn Beta is not recommended for children aged under 18 years. Currently there is no 
information available on the use of VidPrevtyn Beta in children and adolescents younger than years of age. </p>
<p>Other medicines and VidPrevtyn Beta 
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other 
medicines or vaccines. </p>
<p>Pregnancy and breast-feeding<br />
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor, pharmacist or nurse for advice before you receive this vaccine. </p>
<p>Driving and using machines<br />
Some of the side effects of VidPrevtyn Beta mentioned in section 4 (Possible side effects) may 
temporarily affect your ability to drive or use machines. Wait until these effects have worn off before 
you drive or use machines. </p>
<p>VidPrevtyn Beta contains sodium and potassium<br />
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially  sodium-
free .<br />
This medicine contains less than 1 mmol potassium (39 mg) per dose, that is to say essentially 
 potassium-free .  </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Your doctor, pharmacist or nurse will inject the vaccine into a muscle, usually in your upper arm. </p>
<p>You will receive one injection. 
It is recommended that you receive VidPrevtyn Beta once as a booster dose at minimum 4 months 
following the prior vaccination series with either mRNA or adenoviral vector COVID-19 vaccine. </p>
<p>After the injection, your doctor, pharmacist or nurse will watch over you for around 15 minutes to 
monitor for signs of an allergic reaction. </p>
<p>If you have any further questions on the use of this vaccine, ask your doctor, pharmacist or nurse. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store vidprevtyn"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store vidprevtyn"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Most of the side effects occur within 3 days of getting the vaccine and go away within a few days of 
appearing. If symptoms persist, contact your doctor, pharmacist or nurse.  </p>
<p>Get urgent medical attention if you get symptoms of a severe allergic reaction shortly after 
vaccination. Such symptoms may include:  </p>
<ul>
<li>feeling faint or light-headed  </li>
<li>changes in your heartbeat  </li>
<li>shortness of breath  </li>
<li>wheezing </li>
<li>swelling of your lips, face, or throat  </li>
<li>itchy swelling under the skin (hives) or rash  </li>
<li>feeling sick (nausea) or vomiting  </li>
<li>stomach pain. </li>
</ul>
<p>The following side effects may occur with VidPrevtyn Beta: 
Side effects which may affect up to 1 in 100 people may not have all been detected in the clinical 
studies done to date. </p>
<p>Very common (may affect more than 1 in 10 people):<br />
* Headache 
* Muscle pain 
* Joint pain 
* Feeling unwell 
* Chills 
* Pain where the vaccine is injected </p>
<p>Common (may affect up to 1 in 10 people):<br />
<em> Fever (  38.0 C) 
* Tiredness<br />
</em> Feeling sick (nausea) 
* Diarrhoea 
* Redness or swelling where the vaccine is injected </p>
<p>Uncommon (may affect up to 1 in 100 people): 
* Enlarged lymph nodes 
* Itching, bruising or warmth where the vaccine is injected. </p>
<p>Rare (may affect up to 1 in 1,000 people) 
* Dizziness </p>
<p>Not known (cannot be estimated from available data): 
* Allergic reactions such as rash or hives or swelling of the face 
* Severe allergic reactions (anaphylaxis) </p>
<p>Reporting of side effects<br />
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects you can help provide more information on the 
safety of this medicine. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this vaccine out of the sight and reach of children. </p>
<p>Information about storage, use and handling are described in the section intended for healthcare 
professionals at the end of the package leaflet. </p>         </div>"""      

